Navigation Links
GNS Healthcare Collaborates With A Leading CRO To Enable More Efficient And Cost-Effective Drug Development
Date:9/19/2012

CAMBRIDGE, Mass., Sept. 19, 2012 /PRNewswire/ -- GNS Healthcare, Inc. (GNS), the leading healthcare data analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Covance, one of the world's largest and most comprehensive contract research organizations. The collaboration is focused on developing novel data-driven models that will assist pharmaceutical companies in optimizing the efficiency and cost-effectiveness of drug development activities. Combining GNS's supercomputer-driven REFS™ (Reverse Engineering and Forward Simulation) big data analytics platform and Covance's data assets derived from its extensive clinical and scientific support of pharmaceutical drug development, the companies will create computer models that predict the likelihood of development success for a drug candidate given available safety and efficacy data across a variety of patient characteristics, across many diseases, starting with Type II Diabetes. Financial terms of the agreement were not disclosed.

"Our collaboration with Covance combines our unique collective resources and capabilities to tackle what has previously been an intractable challenge—improving dismal clinical drug development success rates," said Colin Hill, President, CEO and co-founder of GNS Healthcare. "The predictive computer models arising from our collaboration will address this problem and will in turn lead to better treatment options for patients. The collaboration with Covance is a key part of our expanding portfolio of relationships with customers and partners employing the REFS™ platform to learn what drugs work for whom in healthcare."

This collaboration complements GNS' existing work with several major pharmaceutical companies in creating treatment algorithms to match patients to drugs and to discover novel biomarkers from wide-ranging molecular and clinical trial data.

About REFS™
REFS™ (Reverse Engineering and Forward Simulation) is GNS Healthcare's scalable, supercomputer-enabled framework for discovering new knowledge directly from data. REFS™ automates the discovery and extraction of causal network models from observational data and uses high-throughput simulations to generate new knowledge.

About GNS Healthcare
GNS Healthcare is a 'Big Data' analytics company that has developed a scalable approach for the discovery of what works in healthcare, and for whom. GNS analytics solutions are being applied across the healthcare industry: from pharmaceutical and biotechnology companies, health plans and hospitals, to integrated delivery systems, Pharmacy Benefits Managers (PBMs) and Accountable Care Organizations (ACOs). GNS Healthcare discovers the knowledge needed to match patients with treatments that work. www.gnshealthcare.com

CONTACT:
GNS Healthcare Inc.
Thomas A. Neyarapally, 617-494-0492
SVP, Corporate Development


'/>"/>
SOURCE GNS Healthcare, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Healthcare Hospitals Ranked as "Top Performers" by The Joint Commission
2. Omron Healthcare Announces New Over-The-Counter Electrotherapy Device
3. Donor Alliance Named Colorados Top Healthcare Company
4. Genelex Corporation Rolls Out Lifesaving DNA Healthcare System
5. AVT Develops New Line of Automated Stores For the Healthcare Industry
6. Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
7. H. D. Smith Names Timothy Booth Corporate VP, Home Healthcare (HHC), In First-of-its-Kind Leadership Appointment
8. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
9. Covance to Present at the Morgan Stanley Global Healthcare Conference
10. Amgen To Present At The Morgan Stanley Global Healthcare Conference
11. Feds Use Tougher Tactics To Fight Healthcare Fraud
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
(Date:9/9/2017)... 2017 ... coming to Washington DC ... Tuesday, September 12 th – Monday, September 18 th .The Brain ... MRI brain scans to the public.Where:  BTF,s Mobile ... 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road ...
(Date:9/7/2017)... Sept. 7, 2017 Caris Life Sciences, ... fulfilling the promise of precision medicine, today announced ... benefits of its molecular profiling approach in guiding ... genomic profiling plus (CGP+) with Caris Molecular Intelligence ... on a molecular level, leading to more therapeutic ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... 19, 2017 , ... The ISO 9001 standard sets out the requirements for ... efficient and improve customer satisfaction. ISO 9001:2015 was released in 2015 and certified organizations ... of September 2018. , As described in this white paper , ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... has agreed to serve as strategic adviser to the animal healthcare division ... of the Bridge Animal Referral Center (BARC) in Edmonds, Washington, which specializes ...
(Date:9/19/2017)... ... , ... Ron Norman, CEO of Team Decades, http://www.teamdecades.com , stressed to ... than generic impression in the job market if one is looking for career expansion. ... that the first impression they give off is not a good one," says Norman, ...
(Date:9/19/2017)... ... 2017 , ... MarkeTouch Media has partnered with fred’s Pharmacy ... modern design with a more streamlined user experience and is designed to improve ... includes hundreds of digital coupons that can be clipped to a customer’s account ...
(Date:9/18/2017)... , ... September 19, 2017 , ... Sarantos ... Fantasy Book This December , Sarantos is proud to be the 1st (and continues ... every new song release. A new song, music video, book chapter and behind the ...
Breaking Medicine News(10 mins):